Rejecting Brand-Liability Theory Post-Mensing

Law360, New York (December 19, 2011, 6:48 PM EST) -- On Sept. 22, 2011, the U.S. Court of Appeals for the Sixth Circuit ruled in Smith v. Wyeth Inc. that former brand manufacturers of Reglan — a prescription drug used to treat certain gastric disorders — could not be held liable for injuries caused by their competitors’ generic versions of the drug. On Nov. 22, 2011, the court denied plaintiffs’ petition for rehearing en banc.

In doing so, the Sixth Circuit became the first appellate court to address, and reject, the argument that the U.S. Supreme...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.